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Abstract
In this study a randomised controlled trial was carried out to investigate the effectiveness of an education programme for patients with
asthma or chronic obstructive pulmonary disease (COPD). All asthma and COPD patients using medication and experiencing pulmonary
symptoms were randomly assigned to the intervention (n = 139) or usual-care group (n = 137). The intervention consisted of taylor-made
education conducted by a general practice assistant and focussing on a patients’ technical skills and coping with the disease. Measurements
took place at baseline, and after 1 and 2 years of follow-up. After 1 and 2 years the inhalation technique was significantly better in the
intervention group compared to the usual-care group. No significant differences were observed regarding disease symptoms, health related
quality of life, compliance, smoking cessation, self-efficacy, and coping. The results only support the implementation of the intervention
regarding the technical skills (inhalation technique). However, given the importance of improvement of patients’ coping and the need for
more efficient care, we recommend further exploration of the possibilities of a more structured and intensive education programme.
© 2003 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
A substantial discrepancy between provided care and
guidelines for adequate treatment has been demonstrated
in patients with (mild to moderate) asthma or chronic ob-
structive pulmonary disease (COPD) in primary care[1,2].
Previous research reported undertreatment, insufficient pa-
tient knowledge (about disease, prescribed medication, and
triggers provoking exacerbation), poor compliance, and an
incorrect inhalation technique[1,3–5]. Health education by
the general practitioner (GP) usually occurs in the early
phase of the disease, or when patients present themselves
∗ Corresponding author. Tel.:+31-20-4448177; fax:+31-20-4448361.
E-mail address:AE.Hesselink.EMGO@med.VU.nl (A.E. Hesselink).
with an exacerbation[2,6]. Without sufficient follow-up,
information may not be easily understood or retained. The
undertreatment of patients with asthma and COPD has also
been attributed to the relative complex treatment schedule
and the high workload of Dutch GPs, as a result of which
disease-specific education may often be neglected[7,8].
Recent reviews have shown that programmes contain-
ing information only, given through a video, booklet or
computer, do not improve health outcomes[9]. Exten-
sive self-management programmes overall did lead to an
improvement of most health outcomes[10,11]. However,
almost all reviewed programmes were carried out among
more severely ill patients, whereas the majority of patients
have mild to moderate asthma or COPD and are treated in
primary care[10,11]. More seriously diseased patients are
seen by a specialist on a regular basis and are probably
0738-3991/$ – see front matter © 2003 Elsevier Ireland Ltd. All rights reserved.
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more motivated, creating better opportunities to integrate
self-management programmes into daily care[12,13]. Nev-
ertheless, patients in primary care do need extra care, and
might benefit from a less extensive programme.
The GP-assistant in The Netherlands gives administrative
support to the GP and assists in minor medical interventions.
In order to improve care, create easily accessible care for pa-
tients, and unburden the GPs, tasks can be delegated to well
trained GP-assistants[14]. We developed a brief education
programme provided by a GP-assistant, that addresses indi-
vidual knowledge and skills regarding the disease, medica-
tion, compliance, inhalation technique, smoking behaviour
and management of disease specific problems which in turn
may also positively influence coping and self-efficacy. This
paper reports on a randomised controlled trial (RCT) on
the effectiveness of this education programme on disease
symptoms and HRQoL, by comparing it with usual-care.
2. Material and methods
2.1. Patient selection
Fourteen GPs from 12 general practices in The Nether-
lands selected patients with asthma or COPD from their
practice records using the following inclusion criteria: a clin-
ical diagnosis of asthma, COPD or mixed disease (asthma
with persisting airway obstruction)[15], age 16–75 years,
treated by the GP, and the absence of other specific pul-
monary or terminal diseases. All patients were invited for
a baseline assessment between January 1998 and January
1999. Based on this assessment, only patients who reported
current use of asthma or COPD medication and experienced
disease symptoms in the past year, like cough and phlegm
production or dyspnea, were included in the study.
2.2. Randomisation and blinding
Enrolled patients were stratified according to age, and
randomly allocated to either the intervention or usual-care
group in blocks of ten. The randomisation was carried out by
an independent person using anonymised patient numbers.
Neither the researcher, nor the data collectors were informed
about the assignment.
2.3. Education programme
The intervention was carried out by two GP-assistants.
The education level of a GP-assistant in The Netherlands is
low to medium and consists of secondary school plus two
years GP-assistant training. Preceding and during the trial
the GP-assistants did receive extra training accomplished
by an experienced GP, and included role-play with video
feedback. The patients allocated to the intervention group
were invited for a consultation with their GP who recorded
information about the diagnosis, medication and circum-
stances causing hyperreactivities. Subsequently, one to four
semi-structured consultations of 30 min with a GP-assistant
took place. The content and number of these consultations
were based on the nature (asthma, COPD or mixed disease)
and seriousness of the disease and the needs and wishes of
the patient. The GP was asked to record the diagnosis of the
disease. The GP-assistant was well instructed and trained
to deal with the differences between the diseases asthma
and COPD. The GP-assistant used a semi-structured proto-
col containing the following topics: (a) information about
the disease, prescribed medication, compliance, and (spe-
cific and/or a-specific) hyperractivity; (b) control and in-
structions on patient’s inhalation technique using a standard-
ised checklist developed by the Dutch Asthma Foundation
[3]; (c) discuss barriers in coping with the disease, such as
how to deal with smoking colleagues; (d) a supportive smok-
ing cessation programme was offered to smokers[16]; and
(e) advice about when to consult a doctor. Finally, if appli-
cable, free booklets (of the Dutch Asthma Foundation) ad-
dressing specific topics such as ‘how do I inform my social
environment’, ‘use of medication’, or ‘dealing with allergy’,
were provided and discussed. During each consultation the
GP-assistant registered on a checklist how well topics were
discussed. All consultations were carried out before the end
of year one. Patients in the usual-care group continued to
receive usual-care from their GPs.
2.4. Measurements
Informed consent was obtained before baseline measure-
ments. Extensive measurements took place before randomi-
sation and after 1 and 2 years follow-up.
2.4.1. Baseline characteristics
Information about education level, duration of their dis-
ease, hyperreactivity (triggers such as smoke and change in
temperature), and other chronic diseases were gathered in
a face-to-face interview. The presence of allergy was de-
fined by a positive Phadiathop test (Pharmacia AB, Uppsala,
Sweden)[17]. The forced expiratory volume in one second
(FEV1) was measured and expressed as a percentage of the
predicted FEV1 (FEV1%predicted) using the adult predicted
normals of the European Coal and Steel[18]. The peakflow
expiratory flow rate (PEFR) was measured every morning
and evening with a hand-held spirometer and recorded ev-
ery three months, over a two week period, on a diary chart
[18]. Variability in PEFR was expressed as lowest morning
PEFR recorded during 14 days and expressed as percent of
the predicted[18,19].
2.4.2. Primary outcome measures
In a face-to-face interview, thedegree of dyspneawas
assessed using the Medical Research Council (MRC) ques-
tionnaire (scale from 0 (no dyspnea) to 4 (very serious
dyspnea)), followed by questions aboutwheezing(never,
ever, or most days and nights), andchronic cough or phlegm
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production (present, not present)[18]. HRQoL was mea-
sured using the written, disease-specific Quality of Life in
Respiratory Illness Questionnaire, which contains 55 items
divided into seven subscales related to breathing problems,
physical problems, emotion, general activity, situation trig-
gers, daily and domestic activities, and social activities[20].
For every item, the extent to which the patient was troubled
due to pulmonary complaints was rated from 1 (not both-
ered at all) to 7 (very much bothered). The subscales were
calculated separately and added to an overall scale (range:
7–49). Finally the scale was transformed so that a low score
indicates poor HRQoL. Using a 2-week diary chart, day or
night disturbance due to respiratory complaints was mea-
sured (no disturbance, disturbance on more than one day
or night) [18]. Finally, the use of-agonists was registered
(use on more or less than 4 out of 14 days)[18].
2.4.3. Secondary outcome measures
To measureinhalation techniquea 10-item validated
inhaler-specific checklist was used[4]. A correct inhalation
technique was defined as less than two negative scores on
the checklist. Inhalation technique could not be measured
at baseline since it was considered to be ethically incorrect
to check a patient’s inhalation technique without adjusting
it when it was incorrect. Information about medication was
gathered from the face-to-face interview and categorised
afterwards according to step-care therapy rules (step 1:
-agonists only; step 2: low or moderate dose corticos-
teroids or cromoglycerine; step 3: moderate dose corticos-
teroides or cromoglycine and long acting-agonists; step
4: high dose corticosteroides or cromoglycine with long
acting-agonists)[15]. In a written questionnaire, informa-
tion was gathered aboutcompliancewith anti-inflammatory
agents using a standardised three-item checklist (compliant
or not compliant), and on smoking behaviour (never, former,
current).Self-efficacywas measured using a disease-specific
questionnaire assessing personal judgements of how well
one can implement adequate behaviour in situations that
involve unpredictable, or stressful elements (range: 0–170)
[21]. Finally, acoping stylequestionnaire was used to mea-
sure how people deal with their disease in everyday life and
is subcategorised in: (a) avoidant or passive coping style
(range: 0–48); (b) rational or problem-focussed coping style
(range: 0–36); and (c) emotional coping style (range: 0–18)
[22].
2.5. Statistical analyses
Study size calculation was based on the ability to detect
a difference in the mean improvement in favour of the in-
tervention group of 10% on the HRQoL scale. To detect a
difference of 10%, a two-sided significance level (α) of 0.05
and a power (1− β) of 0.80, approximately 110 subjects
per group (total 220) were needed. Taking into account a
maximum dropout rate of 20% our goal was to include 132
subjects per group.
Analyses were based on intention-to-treat. Possible prog-
nostic differences between the intervention and usual-care
group were checked at baseline. Change scores were cal-
culated over all outcome measures. To determine the effec-
tiveness of the intervention after 1 and 2 years follow-up,
adjusted for possible clustering of observations within GPs,
linear and logistic multi-level analyses were performed using
MlwiN. The included levels were: (a) patient, (b) GP, and (c)
GP-assistant. When the levels GP and GP-assistant did not
influence outcome, standard linear and logistic regressions
were used. Differences between groups on variables evalu-
ated by the diary charts were analysed when at least three
of the nine charts were available, using multi-level analysis
with time as an additional level.
Finally, subgroup analyses were conducted to investigate
whether the treatment effect varied between patients with
the diagnosis of asthma and COPD (including COPD and
mixed disease) and between males and females. Another
subgroup analysis was conducted to analyse the effect of the




Of the 663 patients selected by the GPs and invited for
baseline assessment, 124 could not be contacted, while 63
refused to participate (Fig. 1). Among the non-responders,
there were significantly more males and younger patients.
Of the 476 patients assessed, 276 (58%) patients met all
inclusion criteria and were randomly allocated to either the
intervention (n = 139) or usual-care group (n = 137).
After one year 17% in the intervention group versus
31% in the usual-care group were lost to follow-up, after
2 years these percentages were 31% versus 42% (Fig. 1).
Patients with only a baseline measurement (n = 67) were
compared to those with at least one follow-up measurement
(n = 209). More patients in the usual-care group and more
(ex-)smokers dropped out from the study (p < 0.01). There
were no differences in baseline characteristics between pa-
tients lost to follow-up in the intervention group compared
to those in the usual-care group.
3.2. Treatment during the intervention
Of the intervention group 12 patients (9%) did not partic-
ipate in the intervention; three refused, five moved, and four
could not be reached. The number of consultations with
the GP-assistant differed, 47 patients had one, 55 had two
and 25 had more than two consultations. Problem-specific
booklets were handed out to 99 patients. According to
the registration-form of the GP-assistant, at the final con-
sultation 79% of the patients had a sufficient inhalation
technique, and most patients sufficiently understood their
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 intervention usual-care 
Randomized 
(n=276) 
Baseline n=139 (100%) 
12 patients did not receive 
the intervention  
After one year n=115 (83%) 
 - 8 had moved   
-  12 refused  
-  4 could not be contacted 
Not randomized (n= 387), reason: 
- could not be contacted n=124 
- refused to participate n=63 
- did not meet inclusion criteria n=200 
Selected by GP using 
patients records 
(n=663) 
Baseline n=137 (100%) 
After one year n=94 (69%) 
-  11 had moved   
-  22 refused 
-  9 could not be contacted  
-  1 died  
After two years n=96 (69%) 
-   5 had moved   
-   9 refused 
-   5 could not be contacted 
After two years n=80 (58%) 
-  1 had moved   
-  5 refused  
-  8 could not be contacted 
Fig. 1. Flow chart of patients.
disease (78%), hyperreactivity (78%), and the reason for
using a bronchodilator (93%) or corticosteroids (78%).
Multilevel analysis at 1 and 2 years follow-up on all out-
comes showed that observations were independent and not
influenced by the different GPs or GP-assistants (data not
shown). Furthermore, there were no substantial differences
between the intervention and the usual-care group regard-
ing demographic, clinical, or pulmonary function variables
(Table 1). There was only a small difference in baseline
score for self-efficacy, which did not influence the outcomes
(data not shown). Therefore, unadjusted estimates of dif-
ferences between groups were presented for all outcome
measures.
3.3. Primary outcome measures
Only small differences were found in changes of disease
symptoms after 1 and 2 years (Tables 2 and 3). HRQoL
did not change much during the 2 years follow-up and no
significant differences were found between both groups after
1 (−0.3, 95% CI = −1.8, 1.1) and 2 years (−1.2, 95%
CI = −2.9, 0.6) (Table 3). Additional analyses regarding
the subscales of the HRQoL questionnaire also showed no
significant differences. There were small, but insignificant
differences between the intervention and usual-care group
regarding changes in self-efficacy and coping style in favour
of the intervention group.
3.4. Secondary outcome measures
Significantly more patients in the intervention group ver-
sus the usual-care group had a correct inhalation technique
after one (66% versus 50%) and two years (75% versus
59%) follow-up (Table 2). Compliance after 1 and 2 years
was slightly better in the intervention group. The incidence
of smoking cessation was similar in both groups. Four of
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Table 1
Baseline characteristics of participants
Intervention (n = 139) n
(%) or mean± S.D.
Usual-care (n = 137) n
(%) or mean± S.D.
Demographic variables
Gender: male 49 (35) 39 (28)
Age (years) 49.9 ± 14.2 44.7± 13.6
Education level (years) 4.2± 1.6 4.2± 1.6
Smoking
Never 52 (39) 51 (37)
Former 39 (29) 47 (35)
Current 45 (32) 38 (28)
Clinical variables
Diagnosis GP
Asthma 93 (67) 99 (72)
COPD 26 (19) 21 (15)
Mixed disease 20 (14) 17 (13)
Duration of disease (years) 20.8± 16.9 20.6± 15.9
Allergy present 73 (55) 66 (50)
Aspecific hyperreactivity present 104 (77) 99 (75)
Medication (stepped-care therapy)a
Step 1 22 (16) 21 (15)
Step 2 81 (59) 74 (55)
Step 3 28 (20) 30 (22)
Step 4 7 (5) 10 (7)
Other chronic disease 61 (44) 68 (50)
Pulmonary function
Pre-FEV1%predicted 81.9± 22.6 84.7± 23.4
Peakflow (low (morning)%predicted) measured over 14 days (n = 222) 77.1± 19.7 77.2± 21.8
Primary outcome measures
Presence of chronic cough or phlegm production in the last year 54 (39) 49 (36)
Wheezing most days and nights 27 (19) 31 (23)
>1 day or night with respiratory complaints during previous 2 weeks (n = 222) 56 (57) 55 (59)
Use of -agonists in >4 days during previous 2 weeks (n = 222) 66 (64) 77 (72)
Dyspnea grade (scale: 0–4) 1.4± 1.3 1.4± 1.3
Health related quality of life (scale: 7–47) 39.1± 7.1 39.3± 7.1
Secondary outcome measures
Number of not compliant patients (n = 227)b 55 (53) 54 (54)
Self-efficacy (n = 194) 78.7± 27.4 85.8± 27.2
Coping styles (n = 191)
Avoidance 25.2 ± 9.9 25.1± 10.4
Rational reaction 23.4± 6.8 23.0± 7.8
Emotional reaction (mean (IQR))c 2.0 (1.0–5.0) 2.0 (0.0–4.0)
GP: general practitioner; COPD: chronic obstructive pulmonary disease; Pre-FEV1%predicted: forced expiratory volume in one second (FEV1) as a
percentage of the predicted FEV1.
a Step 1:-agonists only; Step 2: low or moderate dose corticosteroids or cromoglycerine; Step 3: moderate dose corticosteroides or cromoglycine
and long acting-agonists; Step 4: high dose corticosteroides or cromoglycine with long acting-agonists.
b Only those using anti-inflammatory agents.
c Median and Inter-Quartile Range (IQR; 25th, 75th percentile) are presented as data are not normally distributed.
the 45 patients in the intervention group who smoked at
baseline stopped smoking versus six out of the 38 in the
usual-care group. After 1 year 21% of the patients in the
intervention group versus 10% in the usual-care group ad-
justed their medication to a higher step. These proportions
were 12% versus 21% after 2 years, compared to base-
line. Reduction in medication was seen in 18% in both
groups after 1 year and in 16% of the patients in the in-
tervention group versus 34% in the usual-care group after
2 years.
At least three day-charts were returned by 174 patients.
The course of symptoms was highly variable over time in
both groups. There were no significant group differences
regarding the number of days or nights disturbed (OR=
0.96; 95% CI = 0.56, 1.61), or daily use of-agonists
(OR = 1.03; 95% CI= 0.52, 2.01) over time.
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Table 2
Change since baseline of categorical data after 1 and 2 years follow-up







After 1 year After 2 years After 1 year After 2 years
Primary outcome measures
No chronic cough and phlegm production or an improvement
IG 43 (40) 41 (44) −6 [−20, 8] 2 [−13, 17]
UC 39 (46) 33 (42)
No wheezing or an improvement
IG 68 (64) 53 (57) 4 [−9, 17] 10 [−5, 25]
UC 51 (60) 37 (47)
Secondary outcome measures
Correct inhalation techniquea
IG 63 (66) 58 (75) 16 [2, 31] 16 [1, 32]
UC 37 (50) 36 (59)
Compliant or an improvement in complianceb
IG 38 (60) 30 (52) 10 [−10, 28] 9 [−11, 29]
UC 22 (50) 17 (43)
a No information was gathered about inhalation technique at baseline
so no change scores after 1 and 2 years could be calculated.
b Compliance was only measured among those using anti-inflammatory
agents.
3.5. Subgroup analysis
Subgroup analysis regarding diagnosis asthma and COPD
showed no differences in outcome across these groups. In
addition, no different effect of the education programme
could be demonstrated between male and female patients.
Subgroup analysis comparing the number of consultations
Table 3






(IG − UC) (%) [95% CI]
After 1 year After 2 years After 1 year After 2 years
Primary outcome measures
Dyspnea grade 0 to 4 (mean± S.D.) IG 1.4± 1.3 0 ± 1.3 0.2± 1.4 0.1 [−0.3, 0.4] 0.1 [−0.3, 0.5]
UC 1.3 ± 1.4 0.1± 1.3 0.3± 1.3
Health related quality of
lifec (mean± S.D.)
IG 39.2 ± 6.6 0.5± 5.2 −0.4 ± 5.9 −0.3 [−1.8, 1.1] −1.2 [−2.9, 0.6]
UC 39.6± 6.6 0.8± 4.1 0.8± 5.3
Secondary outcome measures
Self-efficacyc (mean± S.D.) IG 78.6± 27.1 5.6±19.0 9.5± 23.7 4.3 [−2.6, 11.2] 5.0 [−3.1, 13.1]
UC 87.2± 26.3 1.3± 21.5 4.5± 22.9
Coping style scalesc
Avoidance (mean± S.D.) IG 25.7± 9.9 −1.8 ± 8.7 −1.3 ± 9.9 −0.3 [−3.5, 2.8] 0.3 [−3.1, 3.7]
UC 26.5± 10.1 −1.5 ± 10.6 −1.6 ± 10.1
Rational (mean± S.D.) IG 23.3± 7.7 −2.8 ± 7.4 −2.3 ± 7.2 0.1 [−2.4, 2.5] 0.2 [−2.4, 2.8]
UC 23.2± 6.9 −2.9 ± 7.6 −2.5 ± 8.1
Emotional (median (IQR))c IG 1.3 (1.2, 1.8) 0.6 (−1.2, 1.6) 0.4 (−1.2, 1.3) 0.8 [0, 1.5] 0.4 [−0.5, 1.2]
UC 1.3 (1.0, 1.5) −0.2 (−1.2, 08) 0 (−1.2, 0.5)
a Only patients with at least one follow-up measurement were included.
b Positive results on change scores indicate improvement of dyspnea, HRQoL, self-efficacy, and increasing coping scores.
c Median and Inter-Quartile Range (IQR; 25th, 75th percentile) are presented because of not normally distributed data.
with the GP-assistant (47 patients with one consultation ver-
sus 80 patients with at least two consultations), showed no
differences between groups after one year, but patients with
at least two consultations made less mistakes in their inhala-
tion technique after two years follow-up (66% versus 80%).
4. Discussion and conclusion
The education programme developed for primary care
patients with asthma or COPD resulted in only small and
non-significant changes on disease symptoms or HRQoL.
Inhalation technique, which is required for good disease con-
trol, was significantly better in the intervention than in the
usual-care group.
4.1. Discussion
Because of randomisation, we have no reason to believe
that the inhalation technique was different between groups
at baseline. A significantly better inhalation technique in the
intervention group was seen both after 1 and 2 years. More-
over, inhalation technique was better when patients had more
than one consultation with the GP-assistant. Improvement
of inhalation technique may result in a greater efficacy of
medication and subsequently result in better disease control
and more opportunity to social participation[14,23].
Like our study, previous research has shown that a well
trained GP-assistant is capable of teaching patients how
to use their inhaler correctly and improve their knowledge
about their disease, medication and allergy[14,15]. We did
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not measure the level of knowledge in our study, but since
knowledge has been reported to improve even in less ex-
tensive programmes, we may assume that it also improved
as a result of our programme[9]. A new development in
Dutch primary care is the introduction of a GP-nurse. This
GP-nurse might be even more capable of carrying out our
education programme, as they receive higher and more spe-
cialised education than GP-assistants.
The education programme mainly focussed on individ-
ual training regarding inhalation technique and information
about the disease, medication, hyperreactivity, smoking
and coping. This programme was not sufficiently intensive
to influence psychosocial factors or modify behaviour of
patients, which in turn might have positively influenced
HRQoL. In addition, the GP-assistant was not trained to
offer a self-management or pulmonary rehabilitation pro-
gramme which might have been applicable and effective
patients with more severe or frequent symptoms. Maybe a
more intensive programme conducted by a better trained
health care provider could have influenced a patients dis-
ease symptoms and HRQoL. The programme may also have
been too short to influence the outcome measures. An an-
nual follow-up consultation, which allows the GP-assistant
to review the patient’s knowledge, and to add informa-
tion or discuss new or other problems might be beneficial
[5,11].
The goals we set for our education programme were dif-
ficult to reach. For example, no improvement in compli-
ance was achieved, and few patients stopped smoking. In
a recent review Haynes et al reported that even the most
effective educational interventions do not lead to large im-
provements in compliance[2,11]. Similarly, smoking cessa-
tion may require a more intensive intervention[16,24]. In
addition, changing life style or psychosocial characteristics
like self-efficacy and coping probably need a more intensive
approach.
Finally, few studies among patients with more severe ill-
ness have shown a change in disease symptoms or HRQoL
[6,25]. Our patients had mild to moderate symptoms and
generally good HRQoL scores at baseline. Consequently,
it was difficult to obtain any improvement. Thoonen et al.
[26] evaluated an extensive self-management programme
among asthma patients in primary care, and also could not
accomplish a change in HRQoL. However, they did find
less and less limited activity days in the self-management
group.
No different effect of the education programme was
demonstrated between asthma or COPD patients. All asthma
and COPD patients received a similar education programme
that was mainly aimed at the nature and severity of symp-
toms in each individual patient. More intensive treatments
like a self-management programme have been proven to be
effective in asthma patients but are still under discussion
in COPD patients[15,27]. Since the differences between
asthma and COPD in disease characteristics and treatment
have become more established over the last decade it might
be better to develop different programmes for asthma and
COPD patients[28,29].
In the year of the education programme more patients in
the intervention than in the usual-care group changed their
medication to a higher or lower step. In the year following
the intervention the opposite occurred with more patients in
the usual-care group changing their medication. The differ-
ences between the groups in changes of medication were not
statistically significant. Moreover, the adjustments are diffi-
cult to interpret, as they may depend on a several factors:
changes in severity of symptoms or exacerbations, type of
disease (asthma or COPD), and preferences of GPs and pa-
tients regarding medication. Not all changes in the interven-
tion group may me attributed to recommendations made by
the practice assistant. Consequently, no strong conclusions
can be made regarding changes in medication.
The baseline measurements showed that the randomisa-
tion worked out well in our study. Only a small number (9%)
of the patients refused to participate in the education pro-
gramme, which is in contrast with Youn et al who found that
many asthmatics were not motivated to take part in an ex-
tensive asthma education programme[30]. A relatively large
number of patients dropped out during the study. Like oth-
ers, we found more drop out among (ex-)smokers and among
patients in the usual-care group. No differences were found
in baseline characteristics between patients lost to follow-up
in the intervention or in the usual-care group. Therefore, we
have little reason to believe that the dropout rate greatly in-
fluenced the main results of our study.
4.2. Implications for practice
An education programme, provided by a GP-assistant for
patients with mild to moderate asthma or COPD, resulted
in an improved inhalation technique. However, a more ex-
tensive programme is needed to improve patients’ coping
with the disease as large or significant benefits for disease
symptoms or HRQoL could not be demonstrated. The edu-
cation programme is easy to implement, provides accessible
care, more continuous and patient-tailored care, and may
result in less GP consultations and reduction of the work-
load of GPs[31]. Therefore, we consider it worthwhile to
further investigate the possibilities of a more extensive edu-
cational programme for asthma and COPD in primary care,
continued for a longer period of time, and carried out by an
GP-assistant or a practice nurse[2,3,8].
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